All Stories

  1. Characterisation of the first extended-spectrum β-lactamase (ESBL)-producing Shigella sonnei clinical isolate in Italy
  2. In vitro activity of ceftazidime/avibactam against clinical isolates of ESBL-producing Enterobacteriaceae in Italy
  3. Simplified Testing Method for Direct Detection of Carbapenemase-Producing Organisms from Positive Blood Cultures Using the NG-Test Carba 5 Assay
  4. Evaluation of EDTA- and DPA-Based Microdilution Phenotypic Tests for the Detection of MCR-Mediated Colistin Resistance in Enterobacteriaceae
  5. Novel vanA-carrying plasmid in a clinical isolate of Enterococcus avium
  6. Role of place of acquisition and inappropriate empirical antibiotic therapy on the outcome of extended-spectrum β-lactamase-producing Enterobacteriaceae infections
  7. Emergence of CTX-M-1-producing Salmonella enterica serovar Napoli: A novel ‘enzyme–pathogen association’ in the Italian extended-spectrum β-lactamase (ESBL) endemic context
  8. The EDTA-based disk-combination tests are unreliable for the detection of MCR-mediated colistin-resistance in Enterobacteriaceae
  9. Whole-Genome Sequence of the First Extended-Spectrum β-Lactamase-Producing Strain of Salmonella enterica subsp. enterica Serovar Napoli
  10. Colonization of long-term care facility residents in three Italian Provinces by multidrug-resistant bacteria
  11. Deciphering the complete deletion of the mgrB locus in an unusual colistin-resistant Klebsiella pneumoniae isolate colonising the gut of a traveller returning from India
  12. Mother-to-child transmission of KPC-producing Klebsiella pneumoniae : potential relevance of a low microbial urinary load for screening purposes
  13. Multicenter prospective study on the prevalence of colistin resistance in Escherichia coli: relevance of mcr-1-positive clinical isolates in Lombardy, Northern Italy
  14. Italian nationwide survey on Pseudomonas aeruginosa from invasive infections: activity of ceftolozane/tazobactam and comparators, and molecular epidemiology of carbapenemase producers
  15. Identification by mass spectrometry and automated susceptibility testing from positive bottles: a simple, rapid, and standardized approach to reduce the turnaround time in the management of blood cultures
  16. Strategies for preventing group B streptococcal infections in newborns: a nation-wide survey of Italian policies
  17. Evolving beta-lactamase epidemiology in Enterobacteriaceae from Italian nationwide surveillance, October 2013: KPC-carbapenemase spreading among outpatients
  18. Evaluation of a New Commercial Microarray Platform for the Simultaneous Detection of β-Lactamase and mcr-1 and mcr-2 Genes in Enterobacteriaceae
  19. An allelic variant of the PmrB sensor kinase responsible for colistin resistance in an Escherichia coli strain of clinical origin
  20. First report of NDM-1-producing Klebsiella pneumoniae imported from Africa to Italy: Evidence of the need for continuous surveillance
  21. Mother-To-Child Transmission of KPC Carbapenemase-Producing Klebsiella Pneumoniae at Birth
  22. Evaluation of the in vitro activity of ceftobiprole against clinical isolates of Staphylococcus aureus
  23. Review on colonization of residents and staff in Italian long-term care facilities by multidrug-resistant bacteria compared with other European countries
  24. Erysipelothrix rhusiopathiae bacteremia without endocarditis: rapid identification from positive blood culture by MALDI-TOF mass spectrometry. A case report and literature review
  25. First Detection of themcr-1Colistin Resistance Gene in Escherichia coli in Italy
  26. Comparison of the in-house made Carba-NP and Blue-Carba tests: Considerations for better detection of carbapenemase-producing Enterobacteriaceae
  27. Reporting epidemiology of antibiotic resistance
  28. In VitroActivity of the Novel Antimicrobial Peptide Dendrimer G3KL against Multidrug-Resistant Acinetobacter baumannii and Pseudomonas aeruginosa
  29. Management of carbapenem resistant Klebsiella pneumoniae infections in stem cell transplant recipients: an Italian multidisciplinary consensus statement
  30. Epidemic Diffusion of OXA-23-Producing Acinetobacter baumannii Isolates in Italy: Results of the First Cross-Sectional Countrywide Survey
  31. Cross-Infection of Solid Organ Transplant Recipients by a Multidrug-Resistant Klebsiella pneumoniae Isolate Producing the OXA-48 Carbapenemase, Likely Derived from a Multiorgan Donor
  32. Characterization of resistance mechanisms and genetic relatedness of carbapenem-resistant Acinetobacter baumannii isolated from blood, Italy
  33. Acquisition of plasmid-borne blaIMP-19 gene by a VIM-1-positive Pseudomonas aeruginosa of the sequence type 235 epidemic lineage
  34. FIM-1, a New Acquired Metallo-β-Lactamase from a Pseudomonas aeruginosa Clinical Isolate from Italy
  35. Activity of oritavancin against methicillin-resistant staphylococci, vancomycin-resistant enterococci and  -haemolytic streptococci collected from western European countries in 2011
  36. Epidemiology and genetic characteristics of extended-spectrum  -lactamase-producing Gram-negative bacteria causing urinary tract infections in long-term care facilities
  37. Microarray technology for yeast identification directly from positive blood cultures. A multicenter Italian experience
  38. Emergence of Klebsiella Pneumoniae Producing KPC-Type Enzymes and Infection Control Measures for Containing Hospital Spread
  39. Multifocal diffusion of KPC-3-producing ST512 Klebsiella pneumoniae in Italy
  40. Emergence and spread of a multidrug-resistant Acinetobacter baumannii clone producing both the carbapenemase OXA-23 and the 16S rRNA methylase ArmA
  41. Evaluation of the peptide nucleic acid fluorescence in situ hybridisation technology for yeast identification directly from positive blood cultures: an Italian experience
  42. Persistence of TEM-52/TEM-92 and SHV-12 Extended-Spectrum β-Lactamases in Clinical Isolates of Enterobacteriaceae in Italy
  43. Prevalence and epidemiology of microbial pathogens causing bloodstream infections: results of the OASIS multicenter study
  44. Escherichia coli ST131 Producing Extended-Spectrum  -Lactamases Plus VIM-1 Carbapenemase: Further Narrowing of Treatment Options
  45. Evaluation of NOCOSYSTEM® efficacy in disinfecting surfaces by air
  46. Characterization of pABVA01, a Plasmid Encoding the OXA-24 Carbapenemase from Italian Isolates of Acinetobacter baumannii
  47. Spread of multidrug-resistant Proteus mirabilis isolates producing an AmpC-type β-lactamase: epidemiology and clinical management
  48. First Countrywide Survey of Acquired Metallo-β-Lactamases in Gram-Negative Pathogens in Italy
  49. Diagnostica delle ß-lattamasi a spettro esteso (ESBL) nelle Enterobacteriaceae: problemi e raccomandazioni nella realtà epidemiologica italiana
  50. CORYNEBACTERIUM STRIATUM: EPIDEMIOLOGIA E SENSIBILITÀ AGLI ANTIBIOTICI DI UN PATOGENO EMERGENTE
  51. Biochemical analysis of TEM-134, a new TEM-type extended-spectrum  -lactamase variant produced in a Citrobacter koseri clinical isolate from an Italian hospital
  52. Characterization of the IncA/C plasmid pCC416 encoding VIM-4 and CMY-4 β-lactamases
  53. Drug susceptibility testing of clinical isolates of streptococci and enterococci by the Phoenix automated microbiology system
  54. Spread in an Italian Hospital of a Clonal Acinetobacter baumannii Strain Producing the TEM-92 Extended-Spectrum β-Lactamase
  55. Metallo-β-lactamases as emerging resistance determinants in Gram-negative pathogens: open issues
  56. P948 Risk factors and outcome of bloodstream infections caused by enterobacteria producing extended-spectrum β-lactamases
  57. P1691 Activity of tigecycline against ESBL-producing enterobacteria spreading in Italy
  58. P1005 Resident OXA-51-like carbapenemases in Acinetobacter baumannii: a useful marker for genotyping?
  59. Spread of Enterobacteriaceae carrying the PER-1 extended-spectrum  -lactamase gene as a chromosomal insert: a report from Italy
  60. CTX-M: changing the face of ESBLs in Europe
  61. ATTIVITÀ IN VITRO DI TIGECICLINA SUGLI ENTEROBATTERI PRODUTTORI DI ESBL
  62. RESISTENZA AI FLUOROCHINOLONI IN STREPTOCOCCHI DI GRUPPO G ISOLATI DA PAZIENTI DIABETICI
  63. Use of the Phoenix Automated System for Identification of Streptococcus and Enterococcus spp.
  64. Performance in detection and reporting β-lactam resistance phenotypes in Enterobacteriaceae: a nationwide proficiency study in Italian laboratories
  65. CTX-M-Type Extended-Spectrum β-Lactamases in Italy: Molecular Epidemiology of an Emerging Countrywide Problem
  66. Microbiology of Postoperative Infections
  67. Trends in Production of Extended-Spectrum  -Lactamases among Enterobacteria of Medical Interest: Report of the Second Italian Nationwide Survey
  68. Pseudomonas aeruginosa bloodstream infections: risk factors and treatment outcome related to expression of the PER-1 extended-spectrum beta-lactamase
  69. CMY-16, a Novel Acquired AmpC-Type β-Lactamase of the CMY/LAT Lineage in Multifocal Monophyletic Isolates of Proteus mirabilis from Northern Italy
  70. Failure of levofloxacin treatment in community-acquired pneumococcal pneumonia
  71. INFEZIONI URINARIE RICORRENTI CAUSATE DA ESCHERICHIA COLI
  72. RESISTENZA AD ALTO LIVELLO AI FLUOROCHINOLONI IN UN ISOLATO CILINICO DI STREPTOCOCCUS PNEUMONIAE
  73. Dissemination of CTX-M-Type Extended-Spectrum  -Lactamase Genes to Unusual Hosts
  74. Proteus mirabilis Bloodstream Infections: Risk Factors and Treatment Outcome Related to the Expression of Extended-Spectrum β-Lactamases
  75. Novel TEM-Type Extended-Spectrum β-Lactamase, TEM-134, in a Citrobacter koseri Clinical Isolate
  76. Evolution of CTX-M-type β-lactamases in isolates of Escherichia coli infecting hospital and community patients
  77. Epidemiologia delle batteriemie nosocomiali in Lombardia nel triennio 1999-2001
  78. RESISTENZA MEDIATA DA BETA-LATTAMASI IN ISOLATI CLINICI DI ACINETOBACTER BAUMANNII MDR.
  79. Prevalence and characterization of metallo-β-lactamases in clinical isolates of pseudomonas aeruginosa☆
  80. Emergence in Klebsiella pneumoniae and Enterobacter cloacae Clinical Isolates of the VIM-4 Metallo-β-Lactamase Encoded by a Conjugative Plasmid
  81. Bacteremia Due toKlebsiella pneumoniaeIsolates Producing the TEM‐52 Extended‐Spectrum β‐Lactamase: Treatment Outcome of Patients Receiving Imipenem or Ciprofloxacin
  82. Novel 3-N-Aminoglycoside Acetyltransferase Gene, aac(3)-Ic, from a Pseudomonas aeruginosa Integron
  83. IMP-12, a New Plasmid-Encoded Metallo-β-Lactamase from a Pseudomonas putida Clinical Isolate
  84. Biochemical Characterization of TEM-92 Extended-Spectrum β-Lactamase, a Protein Differing from TEM-52 in the Signal Peptide
  85. Nosocomial Infections Caused by Multidrug-Resistant Isolates of Pseudomonas putida Producing VIM-1 Metallo- -Lactamase
  86. Clonal Diversity and Metallo-β-Lactamase Production in Clinical Isolates ofStenotrophomonas maltophilia
  87. Burkholderia cepacia complex in cystic fibrosis and non-cystic fibrosis patients: identification of a cluster of epidemic lineages
  88. Molecular Characterization of Extended-Spectrum  -Lactamases Produced by Nosocomial Isolates of Enterobacteriaceae from an Italian Nationwide Survey
  89. Occurrence of Extended-Spectrum β-Lactamases in Members of the Family Enterobacteriaceae in Italy: Implications for Resistance to β-Lactams and Other Antimicrobial Drugs
  90. Multidrug-ResistantPseudomonas aeruginosaProducing PER-1 Extended-Spectrum Serine-β-Lactamase and VIM-2 Metallo-β-Lactamase
  91. Multidrug-ResistantPseudomonas aeruginosaProducing PER-1 Extended-Spectrum Serine-β-Lactamase and VIM-2 Metallo-β-Lactamase
  92. Dynamics of a Nosocomial Outbreak of Multidrug-Resistant Pseudomonas aeruginosa Producing the PER-1 Extended-Spectrum  -Lactamase
  93. Properties of multidrug-resistant, ESBL-producing Proteus mirabilis isolates and possible role of β-lactam/β-lactamase inhibitor combinations
  94. Extended-Spectrum TEM- and SHV-Type β-Lactamase-Producing Klebsiella pneumoniae Strains Causing Outbreaks in Intensive Care Units in Italy
  95. PER-1 Extended-Spectrum β-Lactamase Production in anAlcaligenes faecalisClinical Isolate Resistant to Expanded-Spectrum Cephalosporins and Monobactams from a Hospital in Northern Italy
  96. Repeated Epidemics Caused by Extended-Spectrum Beta-Lactamase-Producing Serratia marcescens Strains
  97. Repeated epidemics caused by extended-spectrum beta-lactamase-producingSerratia marcescens strains
  98. Comparative Activity of Piperacillin/Tazobactam against Clinical Isolates of Extended- Spectrum β-Lactamase-Producing Enterobacteriaceae
  99. Extended-Spectrum β-Lactamases Conferring Resistance to Monobactams and Oxyimino-Cephalosporins in Clinical Isolates ofSerratia marcescens
  100. Outbreak of extended-spectrum β-lactamase producingSerratia marcescensin an intensive care unit
  101. Necrotizing Pneumonitis and Empyema Caused by Streptococcus cremoris from Milk